newsfilter
← Latest News
GlobeNewswire·

Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split

PITTSBURGH, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) (the "Company," "our" or "us"), a clinical-stage biotechnology company focused on developing innovative therapies for serious